Regeneus Ltd

ASX:RGS
Deleted on 2024-04-06 00:30:04

Regeneus Ltd

ASX:RGS
Deleted on 2024-04-06 00:30:04
$0.012 (--)
Last close price
--
Rank
0
Held by
2
Followers
Reports My Report Forum Investors
Top member reports
Consensus
mmff
Company Report
Last edited 4 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#135
Performance (52m)
-15.4% pa
Followed by
155
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#New Patent~Japan 9/2/21
stale
mmff
Added 4 years ago
View author's company report

Regeneus Ltd (ASX: RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, announced today that the Japanese Patent Office has decided to grant the Company a new key patent, covering the use of its lead stem cell technology Progenza™ to treat pain, through to 2032.

DISC: I don't hold but do hold OCC

View Attachment